Artificial intelligence is reshaping how topical and transdermal drugs are discovered, formulated, tested, and monitored. What began as isolated experiments in computational chemistry has expanded into a coordinated effort across pharmaceutical companies, CDMOs, dermatology clinics, cosmetics firms, and regulators — all applying AI to solve one of medicine’s oldest challenges: getting a drug through the skin effectively and safely. The market sp…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.